BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 8619611)

  • 1. Coexpression of mammalian cytochrome P450 and reductase in Escherichia coli.
    Dong J; Porter TD
    Arch Biochem Biophys; 1996 Mar; 327(2):254-9. PubMed ID: 8619611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a human cytochrome P450 1A1: rat NADPH-cytochrome P450 reductase fusion protein cDNA and expression in Escherichia coli, purification, and catalytic properties of the enzyme in bacterial cells and after purification.
    Chun YJ; Shimada T; Guengerich FP
    Arch Biochem Biophys; 1996 Jun; 330(1):48-58. PubMed ID: 8651703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baculovirus expression of human P450 2E1 and cytochrome b5: spectral and catalytic properties and effect of b5 on the stoichiometry of P450 2E1-catalyzed reactions.
    Patten CJ; Koch P
    Arch Biochem Biophys; 1995 Mar; 317(2):504-13. PubMed ID: 7893169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cytochrome P450 3A7 in Escherichia coli: effects of 5' modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase.
    Gillam EM; Wunsch RM; Ueng YF; Shimada T; Reilly PE; Kamataki T; Guengerich FP
    Arch Biochem Biophys; 1997 Oct; 346(1):81-90. PubMed ID: 9328287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and coupling of human cytochrome P450 2E1 and NADPH-cytochrome P450 oxidoreductase in dual expression and co-infection systems with baculovirus in insect cells.
    Wang MH; Patten CJ; Yang GY; Paranawithana SR; Tan Y; Yang CS
    Arch Biochem Biophys; 1996 Oct; 334(2):380-8. PubMed ID: 8900414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.
    Yamazaki H; Nakamura M; Komatsu T; Ohyama K; Hatanaka N; Asahi S; Shimada N; Guengerich FP; Shimada T; Nakajima M; Yokoi T
    Protein Expr Purif; 2002 Apr; 24(3):329-37. PubMed ID: 11922748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase.
    Dong MS; Yamazaki H; Guo Z; Guengerich FP
    Arch Biochem Biophys; 1996 Mar; 327(1):11-9. PubMed ID: 8615680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcellular localization, aggregation state, and catalytic activity of microsomal P450 cytochromes modified in the NH2-terminal region and expressed in Escherichia coli.
    Pernecky SJ; Olken NM; Bestervelt LL; Coon MJ
    Arch Biochem Biophys; 1995 Apr; 318(2):446-56. PubMed ID: 7733676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of modified cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity.
    Sandhu P; Baba T; Guengerich FP
    Arch Biochem Biophys; 1993 Nov; 306(2):443-50. PubMed ID: 8215449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of recombinant-expressed cytochrome P450 2C3 from Escherichia coli: 2C3 encodes the 6 beta-hydroxylase deficient form of P450 3b.
    Richardson TH; Hsu MH; Kronbach T; Barnes HJ; Chan G; Waterman MR; Kemper B; Johnson EF
    Arch Biochem Biophys; 1993 Jan; 300(1):510-6. PubMed ID: 8380971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5.
    Shaw PM; Hosea NA; Thompson DV; Lenius JM; Guengerich FP
    Arch Biochem Biophys; 1997 Dec; 348(1):107-15. PubMed ID: 9390180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escherichia coli expression and characterization of cytochromes P450 2B11, 2B1, and 2B5.
    John GH; Hasler JA; He YA; Halpert JR
    Arch Biochem Biophys; 1994 Nov; 314(2):367-75. PubMed ID: 7979377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P450 3A9 expressed in Escherichia coli.
    Wang H; Strobel HW
    Arch Biochem Biophys; 1997 Aug; 344(2):365-72. PubMed ID: 9264551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression, purification, and characterization of a catalytically active human cytochrome P450 1A2:rat NADPH-cytochrome P450 reductase fusion protein.
    Parikh A; Guengerich FP
    Protein Expr Purif; 1997 Apr; 9(3):346-54. PubMed ID: 9126606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme.
    Gillam EM; Baba T; Kim BR; Ohmori S; Guengerich FP
    Arch Biochem Biophys; 1993 Aug; 305(1):123-31. PubMed ID: 8342945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of cytochrome P450-dependent monooxygenases in hamster tissues by fasting.
    Ueng TH; Ueng YF; Chen TL; Park SS; Iwasaki M; Guengerich FP
    Toxicol Appl Pharmacol; 1993 Mar; 119(1):66-73. PubMed ID: 8470125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug metabolism by Escherichia coli expressing human cytochromes P450.
    Parikh A; Gillam EM; Guengerich FP
    Nat Biotechnol; 1997 Aug; 15(8):784-8. PubMed ID: 9255795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Escherichia coli membrane preparations of canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with coexpressed canine cytochrome P450 reductase.
    Locuson CW; Ethell BT; Voice M; Lee D; Feenstra KL
    Drug Metab Dispos; 2009 Mar; 37(3):457-61. PubMed ID: 19074522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a novel host, high-red yeast that stably expresses hamster NADPH-cytochrome P450 oxidoreductase: usefulness for examination of the function of mammalian cytochrome P450.
    Ohgiya S; Goda T; Hoshino T; Kamataki T; Ishizaki K
    Arch Biochem Biophys; 1997 Jul; 343(2):215-24. PubMed ID: 9224733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes.
    Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T
    Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.